Russell Investments Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.61K | Hold |
|
|||||
|
2024
Q2 | $3.87K | Hold |
|
|||||
|
2024
Q1 | $4.01K | Hold |
|
|||||
|
2023
Q4 | $5.84K | Hold |
|
|||||
|
2023
Q3 | $2.96K | Hold |
|
|||||
|
2023
Q2 | $2.36K | Hold |
|
|||||
|
2023
Q1 | $2K | Hold |
|
|||||
|
2022
Q4 | $2.69K | Hold |
|
|||||
|
2022
Q3 | $4K | Hold |
|
|||||
|
2022
Q2 | $7K | Sell |
|
|||||
|
2022
Q1 | $9K | Sell |
|
|||||
|
2021
Q4 | $30K | Sell |
|
|||||
|
2021
Q3 | $45K | Sell |
|
|||||
|
2021
Q2 | $109K | Sell |
|
|||||
|
2021
Q1 | $331K | Buy |
|
|||||
|
2020
Q4 | $22K | Sell |
|
|||||
|
2020
Q3 | $165K | Buy |
|
|||||
|
2020
Q2 | $95K | Buy |
|
|||||
|
2020
Q1 | $12K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $330K | Buy |
|
|||||
|
2017
Q3 | $133K | Buy |
|